NLRP3 and colitis: AMPK inhibitor (Dorsomorphin, 10 mg/kg) not only suppressed p-AMPK and Nrf2 protein expression levels, but also induced NLRP3 and Caspase-1 protein expression levels in DSS-induced colitis mice treated with Schisandrin B, in comparison to the group treated with Schisandrin B (Figure 6A–6D).